Bonesupport Holding AB (BONEX.ST) stock: key figures, P/E, revenue and dividend

Health Care · Sweden · ISIN SE0009858152

Price
319.80 SEK
Market cap
21.36 bn SEK
P/E (2025)
150.22
P/S (2025)
18.19
Dividend yield
0.00 %
Net margin
12.10 %
Return on equity (ROE)
16.37 %
Return on assets (ROA)
13.70 %

Bonesupport Holding AB financials

Fiscal year20242025
Revenue898.00 m SEK1.17 bn SEK
Gross profit832.00 m SEK1.09 bn SEK
Operating income147.71 m SEK277.56 m SEK
EBIT166.00 m SEK276.00 m SEK
Net income133.00 m SEK142.00 m SEK
Diluted EPS – continuing operations2.00 SEK2.13 SEK

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.